z-logo
open-access-imgOpen Access
FLP Recombinase/Estrogen Receptor Fusion Proteins Require the Receptor D Domain for Responsiveness to Antagonists, but not Agonists
Author(s) -
Mark Nichols
Publication year - 1997
Publication title -
molecular endocrinology
Language(s) - English
Resource type - Journals
eISSN - 1944-9917
pISSN - 0888-8809
DOI - 10.1210/me.11.7.950
Subject(s) - biology , fusion protein , estrogen receptor , receptor , recombinase , ligand (biochemistry) , microbiology and biotechnology , binding domain , dna binding domain , transcription factor , biochemistry , binding site , genetics , gene , recombination , recombinant dna , cancer , breast cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom